We are proud of the independent recognition we’ve received.
AbbVie was recognised as one of the Best Super Large Workplaces in Ireland at the 24th annual Great Place to Work 2026 Awards – ranking 3rd. 2026 marked the 13th consecutive year that the company has featured on the list, making AbbVie the highest placed company in the biopharmaceutical/pharmaceutical industry across all categories.
The organisation publishes five lists at its annual awards, with AbbVie joining 20 other companies among Ireland’s Best Super Large Workplaces (more than 550 employees). Additionally, AbbVie was named one of the Best Workplaces for Women for the eighth year in a row.
AbbVie was awarded ‘The Green Lifesciences Award’ at the 2026 Green Awards. The award recognises AbbVie’s environmental sustainability achievements in Ireland, including reductions in energy use and greenhouse gas emissions, water and waste, increased adoption of renewable energy, and the successful delivery of these improvements through employee engagement initiatives.
Launched in 2008, the Green Awards is a leading platform for sustainability intelligence, leadership and innovation in best green practice in Ireland.
AbbVie won two major categories at the Pharma Industry Awards Ireland 2025, winning “Pharma Company of the Year (Large)” and “Biopharma Company of the Year.”
The awards celebrate innovation, business excellence and societal impact and recognise the combined effort of all six AbbVie sites in Ireland.
AbbVie’s commitment to fostering and advancing early career talent was recognised at the gradireland Graduate Recruitment Awards 2025. The graduate organisation presented AbbVie with three trophies, including a gold award for ‘Best Internship Program’ (<50 intake) at the event.
The awards celebrate excellence in graduate recruitment and development in Ireland across a number of key sectors. gradireland is the leading careers platform for students and graduates in Ireland, and the annual awards attract submissions from some of Ireland’s leading companies and organisations.
IE-ABBV-260013
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?